Historical record - last NADAC effective date: 6/23/2021
Product Information
HM COLD-SINUS 200-30 MG CAPLET is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.1642 per EA under NDC 62011007001. Its NADAC has been published 430 times since Nov 28, 2013.
FDA first approved this application on Apr 17, 2001.
Strength
200; 30 mg/1; mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
62011007001
Classification
Generic
Dosage Form
TABLET, SUGAR COATED
Route
ORAL
Effective Date
6/23/2021
Active Ingredients
IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074567FDA Approved
4/17/2001
On Market Since
10/13/2001
Pharmacological Classes
Price Statistics
The NADAC for HM COLD-SINUS 200-30 MG CAPLET has been published 430 times since Nov 28, 2013, and over the history we have for it it has declined 7.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1642 per EA |
|---|---|
| All-time high | $0.1777 (Dec 11, 2013) |
| All-time low | $0.1564 (Sep 23, 2020) |
| Median price | $0.1691 |
| Average price | $0.1683 |
| Largest weekly change | -11.0% (Feb 18, 2015) |
| Weeks tracked | 430 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
0.0%
All
-7.6%
Last surveyed Mar 16, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Ibuprofen and Pseudoephedrine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ibuprofen and Pseudoephedrine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HM COLD-SINUS 200-30 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for HM COLD-SINUS 200-30 MG CAPLET, manufactured by Strategic Sourcing Services LLC, is $0.1642 per EA (NDC 62011007001), effective Mar 16, 2022.
How has the price of HM COLD-SINUS 200-30 MG CAPLET changed over time?
Over the history we have for it, the NADAC for HM COLD-SINUS 200-30 MG CAPLET has declined 7.6%. It has been tracked across 430 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HM COLD-SINUS 200-30 MG CAPLET?
Since Nov 28, 2013, the NADAC for HM COLD-SINUS 200-30 MG CAPLET has ranged from a low of $0.1564 (Sep 23, 2020) to a high of $0.1777 (Dec 11, 2013), with a median of $0.1691 per EA.
Are there cheaper alternatives to HM COLD-SINUS 200-30 MG CAPLET?
No other NADAC-published product currently shares the active ingredient and strength of HM COLD-SINUS 200-30 MG CAPLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HM COLD-SINUS 200-30 MG CAPLET?
HM COLD-SINUS 200-30 MG CAPLET (NDC 62011007001) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.